In Malaria Winmal Q 300mg Injection is an antimalarial medicine and is used alone or with other medications to treat malaria (a serious or life-threatening illness that is spread by a parasite that enters the human body by the bite of infected mosquitoes). However, this medicine should not be used to prevent malaria or to treat severe cases of malaria. This medicine is given by a doctor or nurse and should not be self-administered. Refrain from taking any other medicines or antacids along with this medicine (unless advised by the doctor) as they may affect the absorption of this medicine. Do not use this medicine for treating any other condition without consulting your doctor.
It is not known whether it is safe to consume alcohol with Winmal Q 300mg Injection. Please consult your doctor.
Winmal Q 300mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Winmal Q 300mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Winmal Q 300mg Injection may cause side effects which could affect your ability to drive. Winmal Q 300mg Injection may affect your vision and cause vertigo (dizziness or spinning sensation) which may affect your ability to drive.
Winmal Q 300mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Winmal Q 300mg Injection may be needed. Please consult your doctor.
Winmal Q 300mg Injection should be used with caution in patients with liver disease. Dose adjustment of Winmal Q 300mg Injection may be needed. Please consult your doctor.
If you miss a dose of Winmal Q 300mg Injection, consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Trio Remedies Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: P & B Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Trends Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Wockhardt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Que Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Uni-Pex Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Rhombus Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: McW Healthcare || ₹14.5/tablet (25% cheaper)